65 related articles for article (PubMed ID: 1972352)
1. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.
Madden TD; Harrigan PR; Tai LC; Bally MB; Mayer LD; Redelmeier TE; Loughrey HC; Tilcock CP; Reinish LW; Cullis PR
Chem Phys Lipids; 1990 Mar; 53(1):37-46. PubMed ID: 1972352
[TBL] [Abstract][Full Text] [Related]
2. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient.
Mayer LD; Bally MB; Cullis PR
Biochim Biophys Acta; 1986 May; 857(1):123-6. PubMed ID: 3964703
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
Haran G; Cohen R; Bar LK; Barenholz Y
Biochim Biophys Acta; 1993 Sep; 1151(2):201-15. PubMed ID: 8373796
[TBL] [Abstract][Full Text] [Related]
4. Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA-Lipid Complexes.
Szebeni J; Kiss B; Bozó T; Turjeman K; Levi-Kalisman Y; Barenholz Y; Kellermayer M
ACS Nano; 2023 Jul; 17(14):13147-13157. PubMed ID: 37417667
[TBL] [Abstract][Full Text] [Related]
5. Carbon Dots-Biomembrane Interactions and Their Implications for Cellular Drug Delivery.
Mavroidi B; Kaminari A; Sakellis E; Sideratou Z; Tsiourvas D
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375780
[TBL] [Abstract][Full Text] [Related]
6. A Guide to Your Desired Lipid-Asymmetric Vesicles.
Krompers M; Heerklotz H
Membranes (Basel); 2023 Feb; 13(3):. PubMed ID: 36984654
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Antimicrobial Nano-Drug Delivery Systems.
Zong TX; Silveira AP; Morais JAV; Sampaio MC; Muehlmann LA; Zhang J; Jiang CS; Liu SK
Nanomaterials (Basel); 2022 May; 12(11):. PubMed ID: 35683711
[TBL] [Abstract][Full Text] [Related]
8. Liposomes: structure, composition, types, and clinical applications.
Nsairat H; Khater D; Sayed U; Odeh F; Al Bawab A; Alshaer W
Heliyon; 2022 May; 8(5):e09394. PubMed ID: 35600452
[TBL] [Abstract][Full Text] [Related]
9. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
Glassman PM; Hood ED; Ferguson LT; Zhao Z; Siegel DL; Mitragotri S; Brenner JS; Muzykantov VR
Adv Drug Deliv Rev; 2021 Nov; 178():113992. PubMed ID: 34597748
[TBL] [Abstract][Full Text] [Related]
10. Liposomes for malaria management: the evolution from 1980 to 2020.
Memvanga PB; Nkanga CI
Malar J; 2021 Jul; 20(1):327. PubMed ID: 34315484
[TBL] [Abstract][Full Text] [Related]
11. The Exploitation of Liposomes in the Inhibition of Autophagy to Defeat Drug Resistance.
Condello M; Mancini G; Meschini S
Front Pharmacol; 2020; 11():787. PubMed ID: 32547395
[TBL] [Abstract][Full Text] [Related]
12. Modeling the Distribution of Diprotic Basic Drugs in Liposomal Systems: Perspectives on Malaria Nanotherapy.
Moles E; Kavallaris M; Fernàndez-Busquets X
Front Pharmacol; 2019; 10():1064. PubMed ID: 31611785
[TBL] [Abstract][Full Text] [Related]
13. What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.
Leung AWY; Amador C; Wang LC; Mody UV; Bally MB
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30884782
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Buffers on Weak Acid Uptake by Vesicles.
Hannesschlaeger C; Barta T; Pechova H; Pohl P
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781892
[TBL] [Abstract][Full Text] [Related]
15. Remote loading of liposomes with a
Engudar G; Schaarup-Jensen H; Fliedner FP; Hansen AE; Kempen P; Jølck RI; Kjæer A; Andresen TL; Clausen MH; Jensen AI; Henriksen JR
Theranostics; 2018; 8(21):5828-5841. PubMed ID: 30613265
[TBL] [Abstract][Full Text] [Related]
16. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.
Gilabert-Oriol R; Ryan GM; Leung AWY; Firmino NS; Bennewith KL; Bally MB
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261606
[TBL] [Abstract][Full Text] [Related]
17. Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development.
Wehbe M; Anantha M; Backstrom I; Leung A; Chen K; Malhotra A; Edwards K; Bally MB
PLoS One; 2016; 11(4):e0153416. PubMed ID: 27055237
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticle delivery systems for siRNA-based therapeutics.
Wan C; Allen TM; Cullis PR
Drug Deliv Transl Res; 2014 Feb; 4(1):74-83. PubMed ID: 25786618
[TBL] [Abstract][Full Text] [Related]
19. PEG-polypeptide block copolymers as pH-responsive endosome-solubilizing drug nanocarriers.
Quadir MA; Morton SW; Deng ZJ; Shopsowitz KE; Murphy RP; Epps TH; Hammond PT
Mol Pharm; 2014 Jul; 11(7):2420-30. PubMed ID: 24813025
[TBL] [Abstract][Full Text] [Related]
20. Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.
Ait-Oudhia S; Mager DE; Straubinger RM
Pharmaceutics; 2014 Mar; 6(1):137-74. PubMed ID: 24647104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
